The anticipated end of the due diligence period for the potential sale of MedAdvisor's Australian and New Zealand businesses is approaching, while the company manages challenges in its relationship with one of its largest shareholders. …
MedAdvisor progressing review, including the potential sale of ANZ business
June 27, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Hospital pharmacists use Rare Cancers Awareness Day to call for reform
June 27, 2025 - - Latest News -
MedAdvisor progressing review, including the potential sale of ANZ business
June 27, 2025 - - Latest News -
Mark Butler retains position on critical Cabinet committee
June 26, 2025 - - Latest News -
New Zealand to streamline access to ADHD treatments
June 26, 2025 - - Latest News -
CLEO strengthens FDA submission following Access to globally recognised Biobank
June 25, 2025 - - Australian Biotech -
Leukaemia Foundation calls for urgent action to address diagnosis and treatment gaps
June 25, 2025 - - Latest News -
QBiotics' candidate produces strong efficacy result in soft tissue sarcoma trial
June 25, 2025 - - Latest News